Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- 6 Easy Lifestyle Changes That May Help Prevent Alzheimer’s Disease
- Improving access to medicines for patients with reduced hand function
- How to Increase Mental
- Unexpected GLP-1 side effect? Studies show the meds may help people with addictions
- ASH Volleyball shares gym with rival Pineville during asbestos cleanup
- Redeemed Nutrition marks seven years serving Plainview
- UVA Researchers Help Develop NATO Brain Health Guidelines
- Small Needle, Big Questions: GLP
Browsing: Wellness Tips
A Gallup report reveals that the percentage of Americans using these drugs has nearly quadrupled since 2024. The data points to a decline in obesity, while diabetes rates remain stable and pricing is driving the boom in pharmacy-compounded versions
A registered dietitian and aerial yoga teacher in Waterford is combining nutrition counseling with movement to help people taking GLP-1 medications for weight loss maintain muscle mass
Many GLP-1 clinical trials are not tracking what patients are consuming, pointing to a gap in the weight-loss market. Nutrition Insight asks FrieslandCampina Ingredients, Probi, Roquette, and HTBA what this data gap means for nutrition industry innovators developing solutions for GLP-1 users today.
Mirage News Mirage News Mirage NewsNational09 Jul 2026 8:46 am AESTDate Time European Association for the Study of Obesity
Mirage News Mirage News Mirage NewsScience09 Jul 2026 8:50 am AESTDate Time BMJ Group
(TNND) —A new report from Gallup shows Americans’ use of GLP-1 drugs for weight loss has nearly quadrupled in the last two years
This is a paid press release. Contact the press release distributor directly with any enquiries.
CMS Launches Medicare GLP-1 Bridge for Certain Medicare Part D Beneficiaries Our Privacy Policy has been updated! The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For…
Medifast Inc (ISIN US58470S1024) is a US-based nutrition and weight-loss company whose shares trade in the United States, giving retail investors direct exposure to the evolving weight-management and wellness market. The company has been adjusting its strategy as demand patterns shift across the industry and as consumers increasingly look for structured programs that combine nutrition,…
Doctors are warning about “Ozempic feet,” the unglamorous label for feet that suddenly look bonier, feel more painful, or no longer fit the shoes that were perfectly fine a few months earlier